Related Experiment Video
Updated: Sep 24, 2025

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020
iPSC model of congenital heart disease predicts disease outcome
Dipti Tripathi1, Sushma Reddy1
1Department of Pediatrics (Cardiology) and Cardiovascular Institute, Stanford University, Stanford, CA, USA.
Abstract:
In this issue of Cell Stem Cell, Xu et al. demonstrate that induced pluripotent stem cell-derived cardiomyocytes from patients with hypoplastic left heart syndrome exhibit mitochondrial dysfunction and can be used for disease modeling. In addition, they show the potential to predict future heart failure and develop therapies.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
EPS and iPS Cells in Disease Research
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure

